CARDIOVASCULAR OUTCOMES OF SGLT2 INHIBITORS IN PATIENTS WITH HEART FAILURE AND OBESITY: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

被引：0
|
作者：
De Franca, Ana [1 ]
Krause, Gustavo Pessatto [1 ]
Furtoso, Bruno [1 ]
Senter, Alexandre Moreira [1 ]
Moura, Lidia Zytynski [1 ]
机构：
[1] Pontif Catholic Univ Parana, Curitiba, Parana, Brazil
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1226-135
引用
收藏
页码：429 / 429
页数：1
相关论文
共 50 条
  • [1] SGLT2 Inhibitors in Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials
    Ul Amin, Noor
    Sabir, Faiza
    Amin, Talal
    Sarfraz, Zouina
    Sarfraz, Azza
    Robles-Velasco, Karla
    Cherrez-Ojeda, Ivan
    [J]. HEALTHCARE, 2022, 10 (12)
  • [2] Cardiovascular benefits of SGLT2 inhibitors in patients with heart failure: a meta-analysis of small and large randomized controlled trials
    Shoar, Saeed
    Shah, Ahmed Ali
    Ikram, Waleed
    Farooq, Najam
    Udoh, Agnes
    Tabibzadeh, Elsa
    Khavandi, Soheila
    Khavandi, Siamak
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE, 2021, 11 (03): : 262 - 272
  • [3] Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: A meta-analysis of randomized controlled trials
    Li, Xuexun
    Zhang, Qian
    Zhu, Lingming
    Wang, Guangqiang
    Ge, Peipei
    Hu, Aizhen
    Sun, Xuerong
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 332 : 119 - 126
  • [4] Effect of SGLT-2 inhibitors on cardiovascular outcomes in heart failure patients: A meta-analysis of randomized controlled trials
    Lu, Yuan
    Li, Fei
    Fan, Yong
    Yang, Yu
    Chen, Minglong
    Xi, Jue
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 87 : 20 - 28
  • [5] The Role of SGLT2 Inhibitors on Heart Failure Outcomes in Nondiabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Kommu, Sharath
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2024, 83 (02) : 158 - 166
  • [6] Letter on "Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: A meta-analysis of randomized controlled trials"
    Mo, Manqiu
    Xia, Ning
    Liao, Yunhua
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 346 : 35 - 35
  • [7] SGLT2 inhibitors for prevention of primary and secondary cardiovascular outcomes: A meta-analysis of randomized controlled trials
    He, Guijun
    Yang, Guosu
    Huang, Xiaoyu
    Luo, Duan
    Tang, Chao
    Zhang, Zhen
    [J]. HEART & LUNG, 2023, 59 : 109 - 116
  • [8] Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis
    Gager, Gloria M. M.
    Gelbenegger, Georg
    Jilma, Bernd
    von Lewinski, Dirk
    Sourij, Harald
    Eyileten, Ceren
    Filipiak, Krzysztof
    Postula, Marek
    Siller-Matula, Jolanta M. M.
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [9] Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trials
    Lee, Mei-Chuan
    Hua, Yi-Ming
    Yang, Chun-Ting
    Kuo, Fang-Hsiu
    Chang, Wei-Ting
    Tang, Hsin-Ju
    Toh, Han Siong
    Lin, Yu-Min
    Chen, Sih-Yao
    Chang, Hung-Yu
    Liao, Chia-Te
    [J]. MEDICINE, 2022, 101 (51) : E32489
  • [10] Cardiovascular outcome in patients treated with SGLT2 inhibitors for heart failure: a meta-analysis
    Gager, G. M.
    Gelbenegger, G.
    Jilma, B.
    Von Lewinski, D.
    Sourij, H.
    Eyileten, C.
    Filipiak, K.
    Postula, M.
    Hengstenberg, C.
    Siller-Matula, J.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 1051 - 1051
12345